Collaboration partners and funding sources

Heggebø LC, Fjæra LF, Garrote FLB, Borgen IMH, Blakstad H, Hellebust TP, Saxhaug C, Knutstad K, Rylander H, Henry T, Gustafsson M, Werlenius K, Blomstrand M, Brandal P (2026)
Case Report: Proton beam therapy - friend or foe for patients with IDH-mutated WHO grade 2 and 3 gliomas?
Front Oncol, 16, 1803943
DOI 10.3389/fonc.2026.1803943, PubMed 42180039

Heggebø LC, Johannessen TA, Magelssen H, Sprauten M, Blakstad H, Brekke J, Goplen D, Marienhagen K, Solheim TS, Bjorland L, Brandal P (2026)
Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy
Clin Transl Radiat Oncol, 58, 101140
DOI 10.1016/j.ctro.2026.101140, PubMed 41798870

Mendoza Mireles EE, Blakstad H, Server A, Leske H, Skaga E, Aarhus M, Brandal P, Helseth E, Nayak L, Rønning PA, Vik-Mo EO (2026)
Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study
J Neurooncol, 177 (1)
DOI 10.1007/s11060-026-05481-y, PubMed 41733819